MicroRNAs (miRNAs) are a family of small, noncoding RNAs that repress gene expression at the post--transcriptional level. Over 700 miRNAs have been identified in the human genome, of which 20% to 30% regulate human protein-coding genes. Functional in vitro studies have shown that miRNAs are critical for endothelial cell gene expression and function. miRNAs were found in atherosclerosis, cardiac hypertrophy, arterial hypertension, coronary artery disease, diabetes, and inflammatory diseases. We review the current knowledge about the role of miRNAs in endothelial cells with emphasis on the regulation of cellular senescence, angiogenesis, and vascular inflammation. It has been shown that miR-34a, miR-217, miR-200, miR-146c, and miR-181a are responsible for the regulation of cell stress and proliferation processes. Proangiogenic factors include miR-130a, miR-210, miR-424, miR-17-92, miR-27-b, let-7f, and miR-217, while miR-221 and miR-222 have antiangiogenic properties. Other known miRNAs, including miR-31, miR17-3p, miR-155, miR-221, miR-222, and miR-126, are important factors in the regulation of vascular inflammation. Studies show that miRNA expression analysis can be used in the diagnosis and treatment of various diseases; however, additional research is needed before it is used in routine clinical setting.
Introduction MicroRNAs (miRNAs) are a family of highly conserved noncoding single-stranded RNAs (20-26 nucleotides in length) that regulate gene expression in eukaryotes. They were originally described in C. elegans and have since been identified in many organisms including humans.
1 miRNAs silence gene expression by repressing protein translation or by accelerating messenger RNA (mRNA) degradation.
2 They play an important role in various physio logical and pathological processes including cell proliferation, differentiation, apoptosis, and meta bolism as well as angiogenesis, oncogenesis, and hematopoesis. 3, 4 Over 700 miRNAs have been identified in the human genome so far, and their sequences are deposited in the miRNA database (http://www. mirbase.org). 5 Computational predictions suggest that about 20% to 30% of known human protein--coding genes are regulated by miRNAs. 6 Deregulation of miRNA expression has been reported to be associated with several human diseases (atherosclerosis, cardiac hypertrophy, arterial hypertension, inflammatory diseases). Furthermore, miRNAs present in body fluids are highly tissue specific; therefore, they could represent useful clinical bio markers. 7, 8 miRNAs are transcribed by RNA polymerase II into a primary molecule (pri-miRNA). Long primary transcripts of miRNA are cleaved in the nucleus by RNA-specific RNase III type endonuclease, Drosha, and its cofactor, DiGeorge syndrome critical region (8DGCR8). The 60-70 nt length precursor RNA (pre-miRNA) is actively transported through nuclear pores by the action of Exportin 5 (Exp5) and its partner -Ran GTP-binding protein.
9,10 Pre-miRNAs are then cleaved into ~22-nt duplexes by Dicer, a cytoplasmic RNAse III type endonuclease. Dicer inter-
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Role of microRNAs in endothelial cell pathophysiology miR-221, miR-222, mir-130a, let-7 family, miR-21, and miR-27b. 3 The importance of miRNAs in EC function was demonstrated by the knock down of the Dicer enzyme. Recent data have shown that silencing Dicer results in a significant reduction of the mature miRNA profile. The expression of several significant regulators of angiogenesis, such as endothelial cell-specific receptor kinase, vascular endothelial growth factor receptor 2, endothelial nitric oxide synthase (eNOS), and inter leukin 8, was affected. Silencing Dicer resulted in an increased activation of the eNOS pathway and reduced EC proliferation and cord formation. 16 Another study showed that Dicer and Drosha are involved in the regulation of angiogenesis in vitro. Knocking down of both enzymes alters the reduction of capillary development and tubule forming activity in ECs. Drosha and Dicer small inter fering RNAs (siRNAs) significantly reduced expression of let-7a and miR-27b. The knockdown of Dicer also decreased migration of ECs. 17 To examine the importance of Dicer, another group generated Dicer ex1/2 knockout mice, which have a deletion at the two first exons of the Dicer gene. The homo zygous embryos died between 12.5 and 14.5 days of embryogenesis demonstrating that the presence of Dicer activity is necessary for normal mouse development.
18
The above results show that Dicer and Drosha are the key enzymes in endothelial miRNA formation and maturation and confirm that miRNAs are important in the physio logical function of ECs.
MicroRNAs control endothelial senescence Senescence is connected with cellular response to various environmental stressors and damages defined as permanent cell cycle arrest.
19,20 Senescent cells are important in atherothrombosis and are related to various age-related diseases, including atherosclerosis, and cardiovascular disorders. 21 Of note, cellular senescence plays a pivotal role in protection against cancer.
22
Several miRNAs are involved in the regulatory mechanisms of cellular senescence of ECs. A recent study indicated that miR-34a is already expressed in primary ECs and the degree of expression increases during cell senescence. miR-34a regulates proliferation and differentiation of many cell types, for example in ECs it decreases Sirtuin 1 (silent mating type information regulation 2 homo log; SIRT1) levels.
23 SIRT1 is a longevity gene that protects cells against oxidative and genotoxic stress. Mammalian SIRT1 is a NAD + -dependent class III histone deacetylase and functions as a meta bolic regulator by deacetylation of histones and large numbers of proteins including protein 53 (p53), Ku70 protein, nuclear factor κβ (NF-κβ), and peroxisome proliferator-activated receptor γ.
24 Overexpression of miR-34a in ECs decreases SIRT1 and increases acetylation of p53. Additionally, acetylated tumor suppressor p53 promotes miR-34a expression, which acts with double-stranded (ds)-RNA-binding protein partners, such as trans-activation response RNA-binding protein (TRBP) and protein activator of the interferon-induced protein kinase, PKR, (PACT). In the next stage, mature miRNAs are unwound by helicase A and loaded into the RNA-induced silencing complex (RISC).
11 Only 1 strand of ds-miRNA is incorporated and the other is released or destroyed. The RISC complex consists of the Dicer enzyme and cofactors -TRBP, PACT, Gemin3, and Argonaute 2 (Ago2). The miRISC complex inter acts with mRNA and binds to the complementary sequence in the 3'untranslated region (3'UTR) of target RNA. 12 There are two ways of silencing gene expression depending on the level of complementarity with target mRNA. The nonperfect complementarity with target mRNA leads to translational repression, while full complementarity is required for mRNA degradation (FIGURE). 13 Specific classes of miRNAs were demonstrated to affect the function of endothelial cells (ECs). ECs are involved in many aspects of vascular biology, producing different factors that regulate platelet aggregation, inflammatory cell adhesion, smooth muscle cell proliferation, and vascular tone.
14 miRNA molecules participate in the control of EC-mediated homeostasis. Poliseno et al. To summarize, decreased expression of the above miRNAs could be considered as potential therapeutic targets for delaying senescence, aging processes, and cancer development affecting EC homeostasis.
The function of microRNAs in angiogenesis Angiogenesis is the process of new blood vessel and accelerates suppression of SIRT1 and ultimately results in cell senescence.
23 Overexpression of miR-34a in the endothelial progenitor cells (EPCs) also reduces SIRT1 and remarkably increases cell senescence. Similarly, silencing SIRT1 by siRNA resulted in reduced EPC-induced angiogenesis and increased cell senescence.
25
Another miRNA, named miR-217, is expressed in young HUVECs, human aortic endothelial cells, and human coronary artery endothelial cells. miR-217 promotes endothelial senescence through inhibition of SIRT1, which affects functions of the SIRT1/forkhead box protein O1 (FOXO1) pathway. 26 miR-217 was absent in young cells but increased during endothelial senescence.
26
A recent study has demonstrated that miR-200c influenced growth arrest, apoptosis, and senescence of HUVECs in response to reactive oxygen species (ROS) 43 used a proinflammatory cytokine, tumor necrosis factor α (TNF-α), to induce the generation of several miRNAs in HUVECs. 43 Using the microarray approach, they observed that TNF-α increases the level of miR-155, miR -31, miR-17, miR-191 , and miR-125b. In silico analyses have shown that miR-31 targets selectin E (SELE), miR-17-3p targets inter cellular adhesion molecule 1 (ICAM-1), and miR-155, miR-221, and miR-222 cotarget Ets-1. 43, 42 To examine the role of miR-31 and miR-17-3p in the expression of SELE and ICAM-1 proteins, Suarez et al. 43 transfected HUVECs with sense and antisense miRNA antagomirs. The sense miR-31 and miR-17-3b mimic reduced TNF-α-induced SELE and ICAM-1 levels. Overexpression of sense significantly mimicked reduced neutrophil/endothelial binding, whereas the inhibition of miR-31 and miR-17-3p increased neutrophil adherence to TNF-α stimulated ECs. Results of the study indicate that miR-31 and miR-17-3p are essential for the regulation of neutrophil adhesion through the regulation of SELE and ICAM-1 expression. 42 miR-126 is involved in vascular dysfunction and inflammation. 3 Several studies have shown that miR-126 regulates inflammatory cell migration, capillary network formation, and cell survival. miR-126 has an intronic location in the epithelial growth factor (EGF)-like domain-containing protein 7 (EGFL7) gene and regulates its transcription in ECs. 44 Fish et al. 29 demonstrated that miR-126 regulated the response of ECs to VEGF through modification of sprouty-related protein with an enabled/VASP homology 1 domain (SPRED1), phosphoinositide-3-kinase regulatory subunit 2 (β) (PIK3R2), the negative regulators of VEGF signaling. 29, 45 Harris et al. 46 found that miR-126 inhibits vascular cell adhesion molecule 1 (VCAM-1) expression, which is involved in leukocyte adhesion to ECs. 46 Inhibition of miR-126 increases proinflammatory TNF-α expression, which activates NF-κβ and inter feron regulatory factor 1, and finally induces expression of VCAM-1 and adhesion of leukocytes to ECs. The angiogenic activity of miR-126 was shown in the zebrafish
and that they affect the expression of the human proto-oncogene c-Kit receptor in ECs. Therefore, they can modulate the activity of stem cell factor, one of the main growth factors involved in cell fate and angiogenesis. Overexpression of miR-221 and -222 in HUVECs significantly reduced cell migration. 15 Dicer silencing has revealed that miR-221 and miR-222 also regulate eNOS in the endothelium. 16 The regulatory mechanisms of nitric oxide (NO) are essential for angiogenesis, capillary network maturation, and vascular remodeling. 32, 33 Other important miRNAs involved in angiogenesis regulation are proangiogenic miR-130a, miR-210,  miR-424, miR27-b, let-7f, and the miR-17-92 cluster.
3 miR-130a regulates expression of growth arrest homeobox (GAX) and homeobox A5 (HoxA5) proteins, which inhibit angiogenesis. 30 GAX is an inhibitory factor, which affects proliferation, migration, and tubulogenic activity of ECs. Also, HoxA5 protein plays a critical role in inhibiting tubule formation in ECs. Fasanaro et al. 34 showed that miR-210 is induced by hypoxia in HUVECs and regulates Ephrin-A3. Upregulated miR-210 affects cell survival, migration, and differentiation in response to hypoxia. 34 Overexpression of miR-210 stimulates primary capillary network formation and the vascular endothelial growth factor (VEGF)-driven cell migration, while silencing of miR-210 inhibits the formation of capillaries and decreases cell migration in normoxia.
34
A more recent study has provided new evidence of the novel miRNA, miR-424, which plays an important role in postischemic vascular remodeling and angiogenesis. 35 miR-424 targets the 3'UTR of cullin 2 (CUL2) gene, inhibits CUL2 expression and finally stabilizes hypoxia-inducible factor 1α (HIF-1α) levels. The concentration of miR-424 is increased in hypoxic ECs and during vascular remodeling in vivo. 35 Transfection of ECs with miR-424 construct increases expression of HIF-1α and HIF-2α, which results in an increased proliferation and migration of ECs. 35 let-7f and miR-27b have been reported to play a significant role in EC-driven angiogenesis. 4 Inhibition of their expression reduces sprout formation by HUVECs.
17
The polycistronic cluster, miR-17-92, consists of several miRNAs: miR-17, miR-18a, miR-19a, miR-20a, miR-19b , and miR-92a. 36 miR-17-92 is the first miRNA with oncogenic activity, which promotes angiogenesis of tumor endothelium through downregulation of thrombospondin 1 (antiangiogenic molecules) and connective tissue growth factor. 37 Another study has shown that the miR-17-92 cluster targets p53-mediated transcriptional repression in hypoxia. 33 Dews et al. 38 suggested that miR-92a is a negative regulator of angiogenesis in ECs. Overexpression of miR17, miRNAs) and miRNA mimics to modulate biological function in the pathology of diseases. Moreover, exogenous miRNAs could be useful in the treatment of many diseases, because they are upstream regulators of gene expression involved in modification of EC activity. Further research on the roles of miRNAs in vascular disease is required for the future development of miRNA therapeutics. and mice with the knockdown of miR-126 causing a loss of vascular integrity. 4 Thus, miR-126 can modify vascular inflammation through suppression of leukocyte adhesion to ECs. 46 miR-155, miR-221, and miR-222 generated by HUVECs regulate Ets-1 transcription factor. 42 Ets-1 is stimulated by angiotensin II, TNF-α, and thrombin and plays a key role in inflammation and microtubule formation by ECs. 43 In addition, miR-155 targets angiotensin II type 1 receptor (AT1R) activity. 44 Activation of AT1R by angiotensin II initiates endothelial dysfunction, structural remodeling, and vascular inflammation. 47 miR-155, miR-221 and -miR-222 have been reported to regulate inflammatory response in ECs mediated by angiotensin II. 42 miR-155 also regulates expression of adhesion molecules in inflammatory ECs. 42 A silent polymorphism +1166 A/C of the 3'UTR of the AT1R gene was reported to be a response to vascular inflammation and cardiovascular complications. 48 The presence of +1166C allele inter feres with the ability of miR-155 to inter act with the binding site. 48 Recent studies have revealed that microvesicles, exosomes, and apoptotic bodies can transfer miRNA. 49 It is possible that this is a novel genetic exchange between adjacent or distant cells. The tissue-specific miRNAs released into body fluids might serve as para crine signaling molecules and reflect physio logical and/or pathological conditions. For this reason, miRNAs are emerging as inter esting, noninvasive early diagnostic bio markers. Fichtlscherer et al. 50 suggested that the levels of circulating miRNAs associated with vascular and inflammatory conditions were downregulated in coronary artery disease. 50 Another group demonstrated that the levels of antiangiogenic miR-503 is upregulated in diabetic patients with critical limb ischemia. 51 The plasma level of miR-503 is significantly increased in these patients in comparison with controls and can serve as a potential circulating marker of ongoing ischemia. However, there are some limitations of the use of circulating miRNA as biomarkers. Multiple para meters, such as changes in expression in tissue, secretion of miRNA by cells, and stability of miRNA molecules, may influence its levels in plasma or serum. In addition, determining absolute amounts of miRNA has not been well-established because there is no stable control of miRNA, especially in disease conditions. In summary, the results described above indicate that several types of miRNAs can target a different aspect of EC/vessel wall/blood homeostasis. These findings also provide possible future therapeutic inter vention for diseases connected with endothelial dysfunction. Circulating miRNAs could be measured in body fluids as early bio markers for disease diagnosis, prognosis, and response to treatment, but large-scale studies are required to confirm potential usefulness as predictive markers. Knowledge about miRNAs provides an opportunity to use antagomirs (oligonucleotide inhibitors to silence endogenous
